Vividion Therapeutics
Developing drugs for oncology and immunology using chemoproteomics.
H-1B sponsor history — This employer has had H-1B petitions approved by USCIS in the last five fiscal years, per the USCIS H-1B Employer Data Hub. The approval belongs to the employer and is not a commitment to sponsor this role.
biotechpharmaceuticals
Company facts
- Founded
- 2016
- Employees
- 270
- Headquarters
- United States
- Type
- Private
- Funding
- Series C · $135M · 2021
- Subsidiaries
- Tavros Therapeutics
